Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel - Effect of additives

Journal of Controlled Release

Volumn 105, Issue 1-2, 2005, Pages 52-67

  Shikanov, Ariella ^a   Ezra, Aviva ^a   Domb, Abraham J ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Additives; Biodegradable polymer; Implant; Paclitaxel; Poly(ester anhydride)

Indexed keywords

ADDITIVES; BIODEGRADATION; PHOSPHOLIPIDS; POLYMERS; SYNTHESIS (CHEMICAL); VISCOSITY;

PACLITAXEL; POLY(SEBACIC ACID-CO-RICINOLEIC ACID); POLYMER DEGRADATION; SURGICAL PASTES;

CARBOXYLIC ACIDS;

DRUG CARRIER; MACROGOL 2000; MACROGOL 400; PACLITAXEL; POLY(SEBACIC ACID CO RICINOLEIC ACID); RICINOLEIC ACID; SEBACIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SYNTHESIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; VISCOSITY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DECANOIC ACIDS; DRUG CARRIERS; FEMALE; HYDROLYSIS; MICE; MICE, INBRED C3H; PACLITAXEL; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYMERS; RICINOLEIC ACIDS; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET; VEHICLES; VISCOSITY;

EID: 20444408397     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.02.018     Document Type: Article

References (25)

1. J.M. Brown, and A.J. Giaccia The unique physiology of solid tumors: opportunities (and problems) for cancer therapy Cancer Res. 58 1998 1408 1416
2. J.K. Jackson, X. Zhang, S. Llewellen, W.L Hunter, and H.M. Burt The characterization of novel polymeric paste formulations for intratumoral delivery Int. J. Pharm. 270 2004 185 198
3. R. Langer Biomaterials in drug delivery and tissue engineering: one laboratory's experience Accounts Chem. Res. 33 2000 94 101
4. A.J. Domb, O. Elmalak, V.R. Shastry, Z. Ta-Shma, D.M. Masters, I. Ringel, D. Teomim, R. Langer, in: A. Domb, J. Kost, D.M. Weismann (Eds.), Handbook of biodegradable polymers, Harwood Academic Publishers, Chichester, UK, p. 135.
5. D. Stephens, L. Li, D. Robinson, S. Chen, H.C. Chang, R.M. Liu, Y.Q. Tian, E.J. Ginsberg, X.Y. Gao, and T.J. Stultz Investigation of the in vitro release of gentamicin from a polyanhydride matrix J. Control. Release 63 2000 305 317
6. J. Bremer S. Numa Fatty Acid Metabolism and its Regulation 1984 Elsevier Amsterdam 113
7. A.J. Domb, and M. Maniar Absorbable biopolymers derived from dimer fatty acids J. Polym. Sci., Part A: Polym. Chem. 31 5 1993 1275
8. D. Teomim, A. Nyska, and A.J. Domb Ricinoleic acid-based biopolymers J. Biomed. Mater. Res. 45 1999 258 267
9. D. Teomim, and A.J. Domb Fatty acid terminated polyanhydrides J. Polym. Sci., Part A: Polym. Chem. 37 1999 3337
10. D.S. Katti, S. Lakshmi, R. Langer, and C.T. Laurencin Toxicity, biodegradation and elimination of polyanhydrides Adv. Drug Deliv. Rev. 54 7 2002 33 961
11. M. Hakkarainen Aliphatic polyesters: abiotic and biotic degradation and degradation products Adv. Polym. Sci. 157 2002 113 138
12. J.M. Meerum Terwogt, B. Nuijen, W.W. Ten Bokkel Huinink, and J.H. Beijen Alternative formulations of paclitaxel Cancer Treat. Rev. 23 1997 87 95
13. S.K. Dordunoo, A.M.C. Oktaba, W. Hunter, W. Min, T. Cruz, and H.M. Burt Release of taxol from poly (ε-caprolactone) pastes: effect of water-soluble additives J. Control. Release 44 1997 87 94
14. A.K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192
15. M.Y. Krasko, A. Shikanov, A. Ezra, and A.J. Domb Poly(ester-anhydrides) prepared by insertion of ricinoleic acid in poly(sebacic acid) J. Polym. Sci., Part A: Polym. Chem. 41 2003 1059 1069
16. Brookfield Engineering Labs., Inc. More solutions to sticky problems. ISO 9001:2000 certified.
17. A. Hatefi, and B. Amsden Biodegradable injectable in situ forming drug delivery systems J. Control. Release 80 2002 9 28
18. B. Vaisman, A. Shikanov, and A.J. Domb Normal phase high performance liquid chromatography for determination of paclitaxel incorporated in a lipophilic polymer matrix J. Chromatogr., A 1064 1 2005 85 95
19. J. Li, X. Ni, and K.W. Leong Injectable drug-delivery systems based on supramolecular hydrogels formed by poly(ethylene oxide)s and α-cyclodextrin J. Biomed. Mater. Res. 65A 2003 196 202
20. A. Shikanov, B. Vaisman, M.Y. Krasko, A. Nyska, and A.J. Domb Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity J. Biomed. Mater. Res. 69A 2004 47 54
21. S.C. Kim, D.W. Kim, Y.H. Shim, J.S. Bang, H.S. Oh, and S.W. Kim In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy J. Control. Release 72 1-3 2001 191 202
22. A.B. Dhanikula, and R. Panchagnula Localized paclitaxel delivery Int. J. Pharm. 183 1999 85 100
23. C.I. Winternitz, J.K. Jackson, M. Oktaba, and H.M. Burt Development of a polymeric surgical paste formulation for taxol Pharm. Res. 13 3 1996 368 375
24. X. Zhang, J.K. Jackson, W. Wong, T. Cruz, W.L. Hunter, and H.M. Burt Development of biodegradable polymeric paste formulations for taxol: an in vitro and in vivo study Int. J. Pharm. 137 1996 199 208
25. J.H. Zar Biostatistical analysis 1996 Prentice-Hall NJ